Biosimilars for the Treatment of Psoriasis A Systematic Review of Clinical Trials and Observational Studies
JAMA Dermatology, 2023.
Duc Binh Phan; Sarah Elyoussfi; Michael Stevenson; Mark Lunt; Richard B. Warren; Zenas Z. N. Yiu
Read publication: JAMA Dermatology
Related
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study...
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Sec...
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective c...
0 Comments